• SENSEX 76,755.05
    -715.06 (--0.92%)
  • BANKNIFTY 57,126.80
    -708.55 (--1.23%)
  • Bharti Airtel
    1,956.00 2,174.70(%)
  • Bluestone Jewel
    872.60 872.60(%)
  • Anthem Bioscienc
    735.10 579.45(%)
  • IndusInd Bank
    1,077.80 1,077.80(%)
  • M & M Fin. Serv.
    384.55 412.30(%)
  • Data Pattern
    4,800.00 4,955.00(%)
  • TVS Motor Co.
    3,965.00 3,970.00(%)
  • Cummins India
    5,635.00 6,142.80(%)
  • Bajaj Auto
    11,025.00 11,025.00(%)
  • SBI Funds Mgt.
    582.55 582.55(%)
  • Bandhan Bank
    169.65 134.30(%)
  • HDFC Bank
    750.25 726.75(%)
  • Kalyan Jewellers
    601.25 617.30(%)
  • Eternal
    275.70 212.55(%)
  • Reliance Industries
    1,284.00 1,253.65(%)
  • Bajaj Finance
    1,056.30 788.40(%)
  • Dixon Technolog.
    13,650.00 9,605.05(%)
  • Himadri Special
    760.20 420.00(%)
  • Titan Company
    4,730.10 4,730.10(%)
  • Nestle India
    1,509.75 1,509.75(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Kilitch Drugs (India) Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 3630.0
  • ISIN : INE729D01010
178.18 -4 (-2.38%)
  • As on 23 Jul 2026 (EOD)

  • Today’s Low

    174.20

  • Today’s High

    183.50

  • Open

    182.53

  • Perv Close

    182.53

  • 52W Low

    117.25

  • 52W High

    227.23

Key Indicators

  • P/E(TTM)

    19.62

  • Mar.Cap (₹Cr.)

    622.95

  • Div & Yield %

    0.00

  • Book Value(₹)

    95.25

  • Debt-Equity Ratio

    -2.38

  • AGM Date

    22-Jul-2026

  • EPS

    9.27

  • P/E Ratio

    19.62

Financials Ratios

  • Debt-Equity Ratio

    0.16

  • Mar.Cap (₹Cr.)

    622.95

  • RONW (%)

    8.28

  • ROCE (%)

    13.30

Score Board

  • Equity (₹ in Cr.)

    34.96

  • BV (₹)

    95.30

  • Sales( ₹ in Cr.)

    188.57

  • NP (in Cr.)

    32.40

  • NP Var(%)

    24.0

  • Div%

    0.0

  • CPS (₹)

    9.90

  • EPS (₹)

    9.30

  • Traded Value (₹ in Lakhs)

    635.95

  • 52 Week High

    227.23

  • 52 Week Low

    117.25

  • Price BSE

    182.0

  • Price NSE

    178.00

  • Market Capital( in Cr.)

    635.95

  • P/C Ratio

    18.30

  • P/E Ratio

    19.60

  • Price Vs.BV

    9.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 181.59 131.60 117.78 105.16 70.02 60.77
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 181.59 131.60 117.78 105.16 70.02 60.77
Other Income 13.72 6.19 4.60 4.56 4.19 5.71
Stock Adjustments 1.17 0.12 -0.23 0.05 -1.09 0.73
Total Income 196.48 137.91 122.15 109.77 73.12 67.21
EXPENDITURE :            
Raw Materials 93.19 66.33 58.27 60.29 37.97 36.49
Power and Fuel Cost 2.61 2.36 2.15 2.00 1.57 1.62
Employee Cost 10.03 7.91 7.47 6.15 5.22 5.65
Other Manufacturing Expenses 5.52 4.69 5.37 5.91 5.48 4.62
Selling and Administration Expenses 38.03 26.70 23.08 16.48 11.11 11.12
Miscellaneous Expenses 2.25 3.29 3.88 3.25 2.25 0.40
Employee Benefit Expenses 10.03 7.91 7.47 6.15 5.22 5.65
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 151.64 111.29 100.22 94.08 63.59 59.91
Operating Profit 44.83 26.62 21.94 15.69 9.53 7.31
Interest 2.40 2.02 1.15 0.80 0.88 0.93
Gross Profit 42.43 24.60 20.79 14.89 8.65 6.38
Depreciation 1.74 1.24 1.34 0.96 1.14 1.15
Profit Before Tax 40.69 23.36 19.45 13.93 7.51 5.23
Current Tax 9.85 6.37 4.20 3.63 1.67 0.70
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.32 -0.59 -0.47 -0.23 -0.31 0.07
Reported Net Profit 31.16 17.57 15.72 10.53 6.16 4.46
Extraordinary Items 4.94 1.01 0.77 1.00 0.94 1.55
Adjusted Net Profit 26.22 16.56 14.95 9.53 5.22 2.91
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 131.53 113.96 98.24 87.71 81.56 78.03
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.93
P & L Balance carried down 162.69 131.53 113.96 98.24 87.71 81.56
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 19.37 10.93 10.09 6.76 3.97 2.89
Earnings Per Share(Adj)-Unit Curr 9.48 5.35 4.94 3.31 1.94 1.41
Book Value 157.28 138.61 122.53 112.65 105.16 98.25
Book Value(Adj)-Unit Curr 76.96 67.82 59.95 55.12 51.46 48.08

Shareholding Pattern

  • Promoter Group

    63.77%

  • Public Share Holding

    36.23%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 13,258,684 37.92 13,258,684 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 9,037,662 25.85 9,037,662 3
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 22,296,346 63.77 22,296,346 4
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 200 0.00 200 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 40,910 0.12 40,910 3
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 41,110 0.12 41,110 4
2] Non Institution
Bodies Corporate 253,622 0.73 253,022 69
Clearing Members 22,433 0.06 22,433 13
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 413,824 1.18 413,824 207
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 545,361 1.56 545,361 386
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 4,255,932 12.17 4,255,932 38
Individuals holding nominal share capital up to Rs. 1 lakh 6,106,498 17.47 5,933,409 11,897
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 800,896 2.29 800,896 1
Sub Total 12,624,108 36.11 12,450,119 12,619
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 34,961,564 100.00 34,787,575 12,627

Company Background

Kilitch Drugs (India) LtdPharmaceuticals - Indian - Formulations

  • Kilitch Drugs (India) Ltd
  • BSE Code : 3630.0
  • ISIN : INE729D01010

  • Incorporation Year

    1992

  • Registered Office

    C-301/2 MIDC TTC Indl Area
    Pawane Village, Thane,
    Maharashtra-400705

  • Telephone

    91-022-27670322/27680913/65144185

  • FAX

    91-022-27680912

  • Chairman

    Mukund P Mehta

  • Managing Director

    Mukund P Mehta

  • Company Secretary

    Pushpa Nyoupane

  • Auditor

    Suryaprakash Maurya & Co/C Sharat & Associates

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Kilitch Drugs (India) Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Kilitch Drugs 181.90 195.30 181.59 19.62 13.14
P & G Health Ltd 6,718.20 944.52 934.17 34.11 71.75
Sanofi India 3,403.50 1,857.10 1,837.40 25.30 54.17
Glaxosmi. Pharma 2,551.10 3,932.76 3,790.20 42.71 58.17
Novartis India 1,699.05 398.23 356.27 45.02 16.64
Cipla 1,415.10 20,102.60 18,979.95 32.52 13.88
Amrutanjan Healt 529.35 469.50 451.82 26.43 21.89
Bliss GVS Pharma 448.15 773.53 729.81 49.09 12.51
Fermenta Biotec. 420.85 442.21 430.53 19.27 17.61
Guj. Themis Bio. 351.75 152.47 150.80 82.18 27.21
Ambalal Sarabhai 31.49 19.52 3.94 22.02 6.77